🇺🇸 FDA
Patent

US 8084234

Isolated nucleic acid molecules encoding a fusion protein capable of binding VEGF

granted A61KA61K38/00A61P

Quick answer

US patent 8084234 (Isolated nucleic acid molecules encoding a fusion protein capable of binding VEGF) held by REGENERON PHARMACEUTICALS, INC. expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/00, A61P, A61P43/00